Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.50 per share. |
01 Aug 2023 |
771 |
57,214
(0%)
|
0%
|
10.5 |
8,096
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.74 per share. |
21 Jun 2023 |
908 |
69,173
(0%)
|
0%
|
11.7 |
10,660
|
Common Stock |
Michelle Berrey
|
President, R&D & CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.04 per share. |
14 Jun 2023 |
1,246 |
81,385
(0%)
|
0%
|
12.0 |
15,002
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
31,659
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
31,756
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
31,558
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
45,998
(0%)
|
0%
|
|
0
|
Common Stock |
Paolo Fundaro
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
43,905
(0%)
|
0%
|
|
0
|
Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
33,598
(0%)
|
0%
|
|
0
|
Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
26,391
(0%)
|
0%
|
|
0
|
Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
32,830
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
8,111 |
30,415
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 May 2023 |
12,547 |
12,547
|
-
|
|
-
|
Option to Purchase Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.07 per share. |
01 May 2023 |
771 |
57,985
(0%)
|
0%
|
17.1 |
13,161
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.19 per share. |
21 Mar 2023 |
909 |
70,081
(0%)
|
0%
|
14.2 |
12,899
|
Common Stock |
Michelle Berrey
|
President, R&D & CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.79 per share. |
14 Mar 2023 |
1,246 |
82,631
(0%)
|
0%
|
15.8 |
19,674
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.21 per share. |
14 Feb 2023 |
386 |
43,291
(0%)
|
0%
|
21.2 |
8,187
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.76 per share. |
01 Feb 2023 |
918 |
58,756
(0%)
|
0%
|
18.8 |
17,222
|
Common Stock |
Michelle Berrey
|
President, R&D & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
14,700 |
83,877
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle Berrey
|
President, R&D & CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
24,000 |
24,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
20,000 |
20,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
12,200 |
43,677
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
14,700 |
70,990
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
24,000 |
24,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
50,400 |
154,640
(0%)
|
0%
|
|
0
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
82,700 |
82,700
|
-
|
|
-
|
Option to Purchase Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
16,000 |
16,000
|
-
|
|
-
|
Option to Purchase Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
9,800 |
36,438
(0%)
|
0%
|
|
0
|
Common Stock |
Jared Freedberg
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
12,200 |
59,674
(0%)
|
0%
|
|
0
|
Common Stock |
Jared Freedberg
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
20,000 |
20,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
16,000 |
16,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2023 |
9,800 |
25,451
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle Berrey
|
President, R&D & CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
765 |
69,177
(0%)
|
0%
|
12.4 |
9,463
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
1,600 |
31,477
(0%)
|
0%
|
12.4 |
19,792
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
718 |
56,290
(0%)
|
0%
|
12.4 |
8,882
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
7,083 |
104,240
(0%)
|
0%
|
12.4 |
87,617
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
1,777 |
26,638
(0%)
|
0%
|
12.4 |
21,981
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
718 |
47,474
(0%)
|
0%
|
12.4 |
8,882
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.37 per share. |
31 Dec 2022 |
675 |
15,651
(0%)
|
0%
|
12.4 |
8,350
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.43 per share. |
21 Dec 2022 |
908 |
57,008
(0%)
|
0%
|
13.4 |
12,194
|
Common Stock |
Michelle Berrey
|
President, R&D and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.94 per share. |
14 Dec 2022 |
1,246 |
69,942
(0%)
|
0%
|
14.9 |
18,615
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.73 per share. |
01 Nov 2022 |
771 |
48,192
(0%)
|
0%
|
15.7 |
12,128
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. |
21 Sep 2022 |
908 |
57,916
(0%)
|
0%
|
14.9 |
13,484
|
Common Stock |
Michelle Berrey
|
President, R&D and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.14 per share. |
14 Sep 2022 |
1,246 |
71,188
(0%)
|
0%
|
17.1 |
21,356
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.06 per share. |
01 Sep 2022 |
597 |
33,077
(0%)
|
0%
|
18.1 |
10,782
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.06 per share. |
01 Sep 2022 |
429 |
16,326
(0%)
|
0%
|
18.1 |
7,748
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.19 per share. |
15 Aug 2022 |
124 |
33,674
(0%)
|
0%
|
18.2 |
2,256
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. |
01 Aug 2022 |
771 |
48,963
(0%)
|
0%
|
12.2 |
9,414
|
Common Stock |
Bryan Ball
|
Chief Qual. Officer & SVP Ops. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.57 per share. |
11 Jul 2022 |
436 |
25,178
(0%)
|
0%
|
14.6 |
6,353
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.48 per share. |
21 Jun 2022 |
3,632 |
58,824
(0%)
|
0%
|
12.5 |
45,327
|
Common Stock |
Michelle Berrey
|
President, R&D and CMO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.10 per share. |
14 Jun 2022 |
4,984 |
72,434
(0%)
|
0%
|
12.1 |
60,306
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
23,548
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
23,645
(0%)
|
0%
|
|
0
|
Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
23,447
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
37,887
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
35,794
(0%)
|
0%
|
|
0
|
Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
25,487
(0%)
|
0%
|
|
0
|
Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
18,280
(0%)
|
0%
|
|
0
|
Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
24,719
(0%)
|
0%
|
|
0
|
Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
7,737 |
22,304
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2022 |
12,790 |
12,790
|
-
|
|
-
|
Option to Purchase Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.88 per share. |
15 May 2022 |
124 |
33,798
(0%)
|
0%
|
17.9 |
2,217
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.71 per share. |
01 May 2022 |
771 |
49,734
(0%)
|
0%
|
15.7 |
12,112
|
Common Stock |
Bryan Ball
|
Chief Qual. Officer & SVP Ops. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.19 per share. |
11 Apr 2022 |
531 |
25,614
(0%)
|
0%
|
17.2 |
9,128
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.93 per share. |
15 Feb 2022 |
171 |
33,922
(0%)
|
0%
|
15.9 |
2,724
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. |
14 Feb 2022 |
529 |
34,093
(0%)
|
0%
|
14.9 |
7,856
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.80 per share. |
12 Feb 2022 |
320 |
35,740
(0%)
|
0%
|
15.8 |
5,056
|
Common Stock |
Jared Freedberg
|
General Counsel |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.91 per share. |
01 Feb 2022 |
4,072 |
50,505
(0%)
|
0%
|
16.9 |
68,858
|
Common Stock |
Michelle Berrey
|
President, R&D and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
17,600 |
17,600
|
-
|
|
-
|
Option to Purchase Common Stock |
Michelle Berrey
|
President, R&D and CMO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
10,300 |
77,418
(0%)
|
0%
|
|
0
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
10,300 |
34,622
(0%)
|
0%
|
|
0
|
Common Stock |
Linda M. Richardson
|
EVP & Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
17,600 |
17,600
|
-
|
|
-
|
Option to Purchase Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
10,300 |
62,456
(0%)
|
0%
|
|
0
|
Common Stock |
Andrew Saik
|
EVP & Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
17,600 |
17,600
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
60,900 |
60,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
35,700 |
111,323
(0%)
|
0%
|
|
0
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
6,600 |
28,415
(0%)
|
0%
|
|
0
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
11,300 |
11,300
|
-
|
|
-
|
Option to Purchase Common Stock |
Jared Freedberg
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
10,300 |
54,577
(0%)
|
0%
|
|
0
|
Common Stock |
Jared Freedberg
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
17,600 |
17,600
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
6,600 |
36,060
(0%)
|
0%
|
|
0
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
11,300 |
11,300
|
-
|
|
-
|
Option to Purchase Common Stock |
Bryan Ball
|
Chief Qual. Officer & SVP Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
6,100 |
6,100
|
-
|
|
-
|
Option to Purchase Common Stock |
Bryan Ball
|
Chief Qual. Officer & SVP Ops. |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
3,600 |
26,145
(0%)
|
0%
|
|
0
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
6,100 |
6,100
|
-
|
|
-
|
Option to Purchase Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jan 2022 |
3,600 |
16,755
(0%)
|
0%
|
|
0
|
Common Stock |
Bryan Ball
|
Chief Qual. Officer & SVP Ops. |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.83 per share. |
11 Jan 2022 |
2,455 |
22,545
(0%)
|
0%
|
16.8 |
41,318
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. |
30 Nov 2021 |
3,817 |
618,894
(1%)
|
0%
|
17.2 |
65,691
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 17.21 per share. |
30 Nov 2021 |
6,138 |
622,711
(1%)
|
0%
|
17.2 |
105,635
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.04 per share. |
12 Nov 2021 |
319 |
31,915
(0%)
|
0%
|
19.0 |
6,074
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.86 per share. |
29 Oct 2021 |
3,817 |
616,573
(1%)
|
0%
|
16.9 |
64,355
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 16.86 per share. |
29 Oct 2021 |
6,138 |
620,390
(1%)
|
0%
|
16.9 |
103,487
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. |
01 Oct 2021 |
289 |
81,564
(0%)
|
0%
|
15.2 |
4,399
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.22 per share. |
01 Oct 2021 |
92 |
23,527
(0%)
|
0%
|
15.2 |
1,400
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.23 per share. |
01 Oct 2021 |
30 |
13,705
(0%)
|
0%
|
15.2 |
457
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. |
30 Sep 2021 |
3,816 |
614,252
(1%)
|
0%
|
14.9 |
56,668
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 14.85 per share. |
30 Sep 2021 |
6,136 |
618,068
(1%)
|
0%
|
14.9 |
91,120
|
Common Stock |
Lisa DeFrancesco
|
SVP, IR & Corp. Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.85 per share. |
30 Sep 2021 |
204 |
10,850
(0%)
|
0%
|
14.8 |
3,029
|
Common Stock |
Lisa DeFrancesco
|
SVP, IR & Corp. Affairs |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.05 per share. |
01 Sep 2021 |
538 |
11,054
(0%)
|
0%
|
15.1 |
8,097
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.05 per share. |
01 Sep 2021 |
524 |
13,735
(0%)
|
0%
|
15.0 |
7,886
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 14.91 per share. |
31 Aug 2021 |
6,138 |
615,749
(1%)
|
0%
|
14.9 |
91,518
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.91 per share. |
31 Aug 2021 |
3,817 |
611,932
(1%)
|
0%
|
14.9 |
56,911
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.28 per share. |
12 Aug 2021 |
319 |
32,234
(0%)
|
0%
|
15.3 |
4,874
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 17.28 per share. |
30 Jul 2021 |
6,138 |
613,428
(1%)
|
0%
|
17.3 |
106,065
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.28 per share. |
30 Jul 2021 |
3,817 |
609,611
(1%)
|
0%
|
17.3 |
65,958
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. |
01 Jul 2021 |
289 |
81,853
(0%)
|
0%
|
20.5 |
5,916
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. |
01 Jul 2021 |
92 |
23,619
(0%)
|
0%
|
20.5 |
1,883
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. |
01 Jul 2021 |
30 |
14,259
(0%)
|
0%
|
20.5 |
614
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 19.97 per share. |
30 Jun 2021 |
6,136 |
611,106
(1%)
|
0%
|
20.0 |
122,536
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.97 per share. |
30 Jun 2021 |
3,816 |
607,290
(1%)
|
0%
|
20.0 |
76,206
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.63 per share. |
28 May 2021 |
3,817 |
604,970
(1%)
|
0%
|
16.6 |
63,477
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 16.63 per share. |
28 May 2021 |
6,138 |
608,787
(1%)
|
0%
|
16.6 |
102,075
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
15,811
(0%)
|
0%
|
|
0
|
Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
15,908
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
15,710
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
30,150
(0%)
|
0%
|
|
0
|
Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
28,057
(0%)
|
0%
|
|
0
|
Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
17,750
(0%)
|
0%
|
|
0
|
Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
17,719 |
17,719
|
-
|
|
-
|
Option to Purchase Common Stock |
Dagmar Rosa-Bjorkeson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
10,543 |
10,543
(0%)
|
0%
|
|
0
|
Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
16,982
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
7,029 |
14,567
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
12,089 |
12,089
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.75 per share. |
12 May 2021 |
319 |
32,553
(0%)
|
0%
|
17.7 |
5,662
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.15 per share. |
08 May 2021 |
128 |
23,711
(0%)
|
0%
|
17.1 |
2,195
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 19.78 per share. |
30 Apr 2021 |
6,138 |
506,466
(1%)
|
0%
|
19.8 |
121,410
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.78 per share. |
30 Apr 2021 |
3,817 |
502,649
(1%)
|
0%
|
19.8 |
75,500
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. |
01 Apr 2021 |
46 |
27,341
(0%)
|
0%
|
24.3 |
1,117
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. |
01 Apr 2021 |
289 |
82,142
(0%)
|
0%
|
24.3 |
7,017
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. |
01 Apr 2021 |
92 |
23,839
(0%)
|
0%
|
24.3 |
2,234
|
Common Stock |
Rocco Venezia
|
Chief Accounting Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.28 per share. |
01 Apr 2021 |
29 |
14,289
(0%)
|
0%
|
24.3 |
704
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 23.08 per share. |
31 Mar 2021 |
6,136 |
503,986
(1%)
|
0%
|
23.1 |
141,619
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.08 per share. |
31 Mar 2021 |
3,658 |
500,328
(1%)
|
0%
|
23.1 |
84,427
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 20.83 per share. |
10 Mar 2021 |
73,441 |
477,129
(1%)
|
0%
|
20.8 |
1,529,776
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 21.29 per share. |
10 Mar 2021 |
147,000 |
640,688
(1%)
|
0%
|
21.3 |
3,129,630
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 21.55 per share. |
10 Mar 2021 |
16,559 |
493,688
(1%)
|
0%
|
21.5 |
356,846
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.66 per share. |
27 Feb 2021 |
357 |
27,387
(0%)
|
0%
|
21.7 |
7,733
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.66 per share. |
26 Feb 2021 |
2,741 |
497,850
(1%)
|
0%
|
21.7 |
59,370
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 21.66 per share. |
26 Feb 2021 |
6,138 |
500,591
(1%)
|
0%
|
21.7 |
132,949
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.12 per share. |
23 Feb 2021 |
319 |
82,431
(0%)
|
0%
|
28.1 |
8,970
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.32 per share. |
12 Feb 2021 |
319 |
32,872
(0%)
|
0%
|
31.3 |
9,991
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.04 per share. |
08 Feb 2021 |
148 |
23,931
(0%)
|
0%
|
36.0 |
5,334
|
Common Stock |
Mark Pruzanski
|
Director |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.24 per share. |
29 Jan 2021 |
2,741 |
494,453
(1%)
|
0%
|
35.2 |
96,593
|
Common Stock |
Mark Pruzanski
|
Director |
Grant, award, or other acquisition of securities at price $ 35.24 per share. |
29 Jan 2021 |
6,138 |
497,194
(1%)
|
0%
|
35.2 |
216,303
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
19,700 |
19,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
12,600 |
27,744
(0%)
|
0%
|
|
0
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
26,900 |
26,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
17,200 |
40,964
(0%)
|
0%
|
|
0
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
46,000 |
82,750
(0%)
|
0%
|
|
0
|
Common Stock |
Jerome B. Durso
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
72,000 |
72,000
|
-
|
|
-
|
Option to Purchase Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
11,500 |
24,079
(0%)
|
0%
|
|
0
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
18,000 |
18,000
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
19,700 |
19,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
12,600 |
33,191
(0%)
|
0%
|
|
0
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
19,700 |
19,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Jason Campagna
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
12,600 |
20,531
(0%)
|
0%
|
|
0
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Sale of securities on an exchange or to another person at price $ 32.78 per share. |
15 Dec 2020 |
1,763 |
27,158
(0%)
|
0%
|
32.8 |
57,791
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.27 per share. |
27 Nov 2020 |
357 |
15,977
(0%)
|
0%
|
37.3 |
13,305
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.47 per share. |
23 Nov 2020 |
319 |
38,784
(0%)
|
0%
|
35.5 |
11,315
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.87 per share. |
13 Nov 2020 |
493 |
24,708
(0%)
|
0%
|
37.9 |
18,670
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.52 per share. |
12 Nov 2020 |
319 |
21,297
(0%)
|
0%
|
38.5 |
12,288
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.15 per share. |
08 Nov 2020 |
128 |
13,314
(0%)
|
0%
|
28.1 |
3,603
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.09 per share. |
01 Oct 2020 |
46 |
16,334
(0%)
|
0%
|
42.1 |
1,936
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
772 |
475,517
(1%)
|
0%
|
42.1 |
32,486
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
296 |
28,921
(0%)
|
0%
|
42.1 |
12,456
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
289 |
39,103
(0%)
|
0%
|
42.1 |
12,161
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
223 |
20,828
(0%)
|
0%
|
42.1 |
9,384
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
92 |
13,442
(0%)
|
0%
|
42.1 |
3,871
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.08 per share. |
01 Oct 2020 |
112 |
8,597
(0%)
|
0%
|
42.1 |
4,713
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.41 per share. |
15 Sep 2020 |
69 |
8,709
(0%)
|
0%
|
43.4 |
2,995
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.81 per share. |
27 Aug 2020 |
357 |
16,380
(0%)
|
0%
|
48.8 |
17,425
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.21 per share. |
23 Aug 2020 |
319 |
39,392
(0%)
|
0%
|
48.2 |
15,379
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 47.44 per share. |
18 Aug 2020 |
1,192 |
8,778
(0%)
|
0%
|
47.4 |
56,543
|
Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 50.55 per share. |
13 Aug 2020 |
54,600 |
5,362,400
(16%)
|
0%
|
50.6 |
2,760,112
|
Common stock, par value $0.001 per share |
Paolo Fundaro
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 46.75 per share. |
13 Aug 2020 |
1,235,512 |
4,000,000
(12%)
|
3%
|
46.8 |
57,760,186
|
Common stock, par value $0.001 per share |
Paolo Fundaro
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 50.15 per share. |
13 Aug 2020 |
126,888 |
5,235,512
(15%)
|
0%
|
50.1 |
6,362,913
|
Common stock, par value $0.001 per share |
Paolo Fundaro
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 52.60 per share. |
13 Aug 2020 |
83,000 |
5,417,000
(16%)
|
0%
|
52.6 |
4,365,451
|
Common stock, par value $0.001 per share |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.86 per share. |
13 Aug 2020 |
493 |
25,201
(0%)
|
0%
|
51.9 |
25,567
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.44 per share. |
12 Aug 2020 |
319 |
21,616
(0%)
|
0%
|
53.4 |
17,047
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.75 per share. |
08 Aug 2020 |
128 |
13,534
(0%)
|
0%
|
48.8 |
6,240
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
46 |
16,737
(0%)
|
0%
|
46.5 |
2,140
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
772 |
476,289
(1%)
|
0%
|
46.5 |
35,913
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
301 |
22,012
(0%)
|
0%
|
46.5 |
14,003
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
615 |
29,217
(0%)
|
0%
|
46.5 |
28,610
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
289 |
39,711
(0%)
|
0%
|
46.5 |
13,444
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
224 |
21,051
(0%)
|
0%
|
46.5 |
10,420
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
92 |
13,662
(0%)
|
0%
|
46.5 |
4,280
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.52 per share. |
01 Jul 2020 |
112 |
9,970
(0%)
|
0%
|
46.5 |
5,210
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.40 per share. |
15 Jun 2020 |
70 |
10,082
(0%)
|
0%
|
77.4 |
5,418
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
8,782
(0%)
|
0%
|
|
0
|
Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
8,879
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
8,681
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel G. Welch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
8,060
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel G. Welch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
23,121
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
21,028
(0%)
|
0%
|
|
0
|
Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
10,721
(0%)
|
0%
|
|
0
|
Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
9,953
(0%)
|
0%
|
|
0
|
Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
2,966 |
2,966
|
-
|
|
-
|
Option to Purchase Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 May 2020 |
1,595 |
7,538
(0%)
|
0%
|
|
0
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.43 per share. |
27 May 2020 |
357 |
16,783
(0%)
|
0%
|
74.4 |
26,572
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.51 per share. |
23 May 2020 |
319 |
40,000
(0%)
|
0%
|
80.5 |
25,683
|
Common Stock |
Paolo Fundaro
|
Director, Ten Percent Owner |
Sale of securities on an exchange or to another person at price $ 84.60 per share. |
13 May 2020 |
595,578 |
5,500,000
(16%)
|
1%
|
84.6 |
50,385,899
|
Common stock, par value $0.001 per share |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.08 per share. |
13 May 2020 |
493 |
25,694
(0%)
|
0%
|
85.1 |
41,944
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.05 per share. |
12 May 2020 |
319 |
21,935
(0%)
|
0%
|
89.1 |
28,407
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.80 per share. |
08 May 2020 |
128 |
13,754
(0%)
|
0%
|
87.8 |
11,238
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 85.95 per share. |
27 Apr 2020 |
181 |
17,140
(0%)
|
0%
|
86.0 |
15,557
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 70.00 per share. |
09 Apr 2020 |
58 |
13,882
(0%)
|
0%
|
70 |
4,060
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.39 per share. |
01 Apr 2020 |
46 |
17,321
(0%)
|
0%
|
58.4 |
2,686
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
568 |
477,061
(1%)
|
0%
|
58.4 |
33,171
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
301 |
22,313
(0%)
|
0%
|
58.4 |
17,578
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
615 |
29,832
(0%)
|
0%
|
58.4 |
35,916
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
289 |
40,319
(0%)
|
0%
|
58.4 |
16,878
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
223 |
21,275
(0%)
|
0%
|
58.4 |
13,023
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
92 |
13,940
(0%)
|
0%
|
58.4 |
5,373
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.40 per share. |
01 Apr 2020 |
112 |
10,152
(0%)
|
0%
|
58.4 |
6,541
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.83 per share. |
15 Mar 2020 |
69 |
10,264
(0%)
|
0%
|
71.8 |
4,956
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.99 per share. |
23 Feb 2020 |
319 |
40,608
(0%)
|
0%
|
95.0 |
30,302
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.24 per share. |
19 Feb 2020 |
170 |
10,333
(0%)
|
0%
|
96.2 |
16,361
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.69 per share. |
13 Feb 2020 |
493 |
26,187
(0%)
|
0%
|
94.7 |
46,682
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.74 per share. |
12 Feb 2020 |
319 |
22,254
(0%)
|
0%
|
96.7 |
30,860
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.17 per share. |
08 Feb 2020 |
148 |
14,032
(0%)
|
0%
|
95.2 |
14,085
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
4,800 |
18,560
(0%)
|
0%
|
|
0
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
7,900 |
7,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 94.04 per share. |
23 Jan 2020 |
723 |
17,837
(0%)
|
0%
|
94.0 |
67,991
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
17,700 |
17,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
10,800 |
477,629
(1%)
|
0%
|
|
0
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
9,200 |
9,200
|
-
|
|
-
|
Option to Purchase Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
5,600 |
26,680
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Bright
|
President, International |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
4,800 |
22,614
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Bright
|
President, International |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
7,900 |
7,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
9,200 |
9,200
|
-
|
|
-
|
Option to Purchase Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
5,600 |
30,447
(0%)
|
0%
|
|
0
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
17,400 |
17,400
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
10,600 |
40,927
(0%)
|
0%
|
|
0
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
8,800 |
8,800
|
-
|
|
-
|
Option to Purchase Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
5,400 |
21,498
(0%)
|
0%
|
|
0
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
5,900 |
5,900
|
-
|
|
-
|
Option to Purchase Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
3,600 |
14,180
(0%)
|
0%
|
|
0
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
4,200 |
22,573
(0%)
|
0%
|
|
0
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
6,900 |
6,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Jason Campagna
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
4,200 |
10,503
(0%)
|
0%
|
|
0
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2020 |
6,900 |
6,900
|
-
|
|
-
|
Option to Purchase Common Stock |
Jason Campagna
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 113.02 per share. |
07 Jan 2020 |
732 |
6,303
(0%)
|
0%
|
113.0 |
82,731
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.93 per share. |
31 Dec 2019 |
54 |
13,760
(0%)
|
0%
|
123.9 |
6,692
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
364 |
13,814
(0%)
|
0%
|
123.9 |
45,107
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
1,166 |
466,829
(1%)
|
0%
|
123.9 |
144,491
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
1,131 |
467,995
(1%)
|
0%
|
123.9 |
140,154
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.50 per share. |
31 Dec 2019 |
100 |
469,226
(1%)
|
0%
|
21.5 |
2,150
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 125.00 per share. |
31 Dec 2019 |
100 |
469,126
(1%)
|
0%
|
125 |
12,500
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Dec 2019 |
100 |
30,084
|
-
|
|
-
|
Option to Purchase Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
809 |
21,080
(0%)
|
0%
|
123.9 |
100,251
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
530 |
17,814
(0%)
|
0%
|
123.9 |
65,678
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
388 |
18,344
(0%)
|
0%
|
123.9 |
48,081
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
669 |
24,847
(0%)
|
0%
|
123.9 |
82,902
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
551 |
25,516
(0%)
|
0%
|
123.9 |
68,280
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
1,151 |
30,661
(0%)
|
0%
|
123.9 |
142,632
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
334 |
30,327
(0%)
|
0%
|
123.9 |
41,389
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
309 |
16,098
(0%)
|
0%
|
123.9 |
38,291
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
340 |
16,407
(0%)
|
0%
|
123.9 |
42,133
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 117.16 per share. |
31 Dec 2019 |
259 |
10,580
(0%)
|
0%
|
117.2 |
30,344
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
106 |
10,839
(0%)
|
0%
|
123.9 |
13,136
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
323 |
10,945
(0%)
|
0%
|
123.9 |
40,026
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Sale of securities on an exchange or to another person at price $ 125.00 per share. |
31 Dec 2019 |
262 |
18,722
(0%)
|
0%
|
125 |
32,750
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.63 per share. |
31 Dec 2019 |
262 |
18,984
(0%)
|
0%
|
54.6 |
14,313
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
349 |
18,373
(0%)
|
0%
|
123.9 |
43,248
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 Dec 2019 |
262 |
20,779
|
-
|
|
-
|
Option to Purchase Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
150 |
7,035
(0%)
|
0%
|
123.9 |
18,588
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 123.92 per share. |
31 Dec 2019 |
259 |
7,185
(0%)
|
0%
|
123.9 |
32,095
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.74 per share. |
27 Dec 2019 |
54 |
15,759
(0%)
|
0%
|
58.7 |
3,172
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Dec 2019 |
54 |
2,883
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Dec 2019 |
416 |
17,692
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 123.24 per share. |
27 Dec 2019 |
1,581 |
14,178
(0%)
|
0%
|
123.2 |
194,842
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.12 per share. |
27 Dec 2019 |
416 |
15,705
(0%)
|
0%
|
59.1 |
24,594
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Dec 2019 |
417 |
30,184
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 125.00 per share. |
26 Dec 2019 |
417 |
469,126
(1%)
|
0%
|
125 |
52,125
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.50 per share. |
26 Dec 2019 |
417 |
469,543
(1%)
|
0%
|
21.5 |
8,966
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Dec 2019 |
54 |
21,041
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.63 per share. |
26 Dec 2019 |
54 |
18,776
(0%)
|
0%
|
54.6 |
2,950
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Sale of securities on an exchange or to another person at price $ 125.00 per share. |
26 Dec 2019 |
54 |
18,722
(0%)
|
0%
|
125 |
6,750
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 119.45 per share. |
19 Dec 2019 |
154 |
7,444
(0%)
|
0%
|
119.4 |
18,395
|
Common Stock |
Jason Campagna
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.16 per share. |
15 Dec 2019 |
80 |
7,598
(0%)
|
0%
|
114.2 |
9,133
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.62 per share. |
03 Dec 2019 |
80 |
18,722
(0%)
|
0%
|
54.6 |
4,370
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Dec 2019 |
80 |
21,095
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.12 per share. |
27 Nov 2019 |
875 |
16,634
(0%)
|
0%
|
59.1 |
51,730
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Nov 2019 |
52 |
2,937
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
27 Nov 2019 |
875 |
18,108
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.16 per share. |
27 Nov 2019 |
357 |
15,289
(0%)
|
0%
|
109.2 |
38,970
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 101.65 per share. |
27 Nov 2019 |
1,040 |
15,646
(0%)
|
0%
|
101.7 |
105,716
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.73 per share. |
27 Nov 2019 |
52 |
16,686
(0%)
|
0%
|
58.7 |
3,054
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
1,750 |
23,250
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
106 |
2,989
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
4,267 |
18,983
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
105 |
3,095
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
25 Nov 2019 |
4,373 |
15,759
(0%)
|
0%
|
100 |
437,300
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.74 per share. |
25 Nov 2019 |
106 |
20,132
(0%)
|
0%
|
58.7 |
6,226
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.12 per share. |
25 Nov 2019 |
4,267 |
20,026
(0%)
|
0%
|
59.1 |
252,265
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
25 Nov 2019 |
1,855 |
15,759
(0%)
|
0%
|
100 |
185,500
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 58.74 per share. |
25 Nov 2019 |
105 |
17,614
(0%)
|
0%
|
58.7 |
6,168
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 59.12 per share. |
25 Nov 2019 |
1,750 |
17,509
(0%)
|
0%
|
59.1 |
103,460
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.67 per share. |
25 Nov 2019 |
14,524 |
483,689
(1%)
|
0%
|
8.7 |
125,875
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.67 per share. |
25 Nov 2019 |
39 |
469,165
(1%)
|
0%
|
8.7 |
338
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
25 Nov 2019 |
14,563 |
469,126
(1%)
|
0%
|
100 |
1,456,300
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.67 per share. |
25 Nov 2019 |
19,880 |
489,006
(1%)
|
0%
|
8.7 |
172,294
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.50 per share. |
25 Nov 2019 |
15,557 |
504,563
(1%)
|
0%
|
21.5 |
334,476
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 100.00 per share. |
25 Nov 2019 |
35,437 |
469,126
(1%)
|
0%
|
100 |
3,543,700
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
39 |
0
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
14,524 |
19,880
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
19,880 |
0
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Nov 2019 |
15,557 |
30,601
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.89 per share. |
23 Nov 2019 |
460 |
31,812
(0%)
|
0%
|
88.9 |
40,889
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 85.00 per share. |
19 Nov 2019 |
1,550 |
15,759
(0%)
|
0%
|
85 |
131,750
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
19 Nov 2019 |
8,325 |
26,475
|
-
|
|
-
|
Option to Purchase Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Sale of securities on an exchange or to another person at price $ 85.00 per share. |
19 Nov 2019 |
3,829 |
21,889
(0%)
|
0%
|
85 |
325,465
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Sale of securities on an exchange or to another person at price $ 85.00 per share. |
19 Nov 2019 |
8,325 |
25,718
(0%)
|
0%
|
85 |
707,625
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. |
19 Nov 2019 |
8,325 |
34,043
(0%)
|
0%
|
53.4 |
444,638
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 85.00 per share. |
13 Nov 2019 |
946 |
17,309
(0%)
|
0%
|
85 |
80,410
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Sale of securities on an exchange or to another person at price $ 85.00 per share. |
13 Nov 2019 |
500 |
26,429
(0%)
|
0%
|
85 |
42,500
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Nov 2019 |
500 |
34,800
|
-
|
|
-
|
Option to Purchase Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.92 per share. |
13 Nov 2019 |
711 |
25,718
(0%)
|
0%
|
83.9 |
59,667
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.41 per share. |
13 Nov 2019 |
500 |
26,929
(0%)
|
0%
|
53.4 |
26,705
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.02 per share. |
12 Nov 2019 |
319 |
18,642
(0%)
|
0%
|
83.0 |
26,483
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 82.76 per share. |
08 Nov 2019 |
128 |
11,268
(0%)
|
0%
|
82.8 |
10,593
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 75.00 per share. |
29 Oct 2019 |
595 |
18,732
(0%)
|
0%
|
75 |
44,625
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 70.00 per share. |
23 Oct 2019 |
58 |
11,396
(0%)
|
0%
|
70 |
4,060
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
46 |
18,255
(0%)
|
0%
|
65.9 |
3,030
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
1,547 |
469,126
(1%)
|
0%
|
65.9 |
101,901
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
530 |
19,327
(0%)
|
0%
|
65.9 |
34,911
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
626 |
26,067
(0%)
|
0%
|
65.9 |
41,235
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
417 |
32,272
(0%)
|
0%
|
65.9 |
27,468
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
267 |
16,747
(0%)
|
0%
|
65.9 |
17,587
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.87 per share. |
01 Oct 2019 |
92 |
11,454
(0%)
|
0%
|
65.9 |
6,060
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Sale of securities on an exchange or to another person at price $ 70.00 per share. |
16 Sep 2019 |
800 |
11,546
(0%)
|
0%
|
70 |
56,000
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 60.32 per share. |
28 Aug 2019 |
5,207 |
403,688
(1%)
|
0%
|
60.3 |
314,086
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.50 per share. |
27 Aug 2019 |
357 |
18,301
(0%)
|
0%
|
60.5 |
21,599
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.90 per share. |
23 Aug 2019 |
319 |
32,689
(0%)
|
0%
|
60.9 |
19,427
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 64.30 per share. |
20 Aug 2019 |
1,180 |
398,481
(1%)
|
0%
|
64.3 |
75,874
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 65.85 per share. |
20 Aug 2019 |
37,604 |
368,301
(1%)
|
0%
|
65.8 |
2,476,223
|
Common Stock |
Srinivas Akkaraju
|
Director |
Purchase of securities on an exchange or from another person at price $ 67.12 per share. |
20 Aug 2019 |
29,000 |
397,301
(1%)
|
0%
|
67.1 |
1,946,480
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.03 per share. |
13 Aug 2019 |
689 |
26,429
(0%)
|
0%
|
66.0 |
45,495
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.89 per share. |
12 Aug 2019 |
319 |
18,961
(0%)
|
0%
|
65.9 |
21,019
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.05 per share. |
08 Aug 2019 |
128 |
12,346
(0%)
|
0%
|
66.0 |
8,454
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.71 per share. |
13 Jul 2019 |
111 |
17,014
(0%)
|
0%
|
69.7 |
7,738
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
46 |
18,658
(0%)
|
0%
|
79.2 |
3,642
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
1,548 |
470,673
(1%)
|
0%
|
79.2 |
122,555
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 78.66 per share. |
01 Jul 2019 |
595 |
19,857
(0%)
|
0%
|
78.7 |
46,803
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
530 |
20,452
(0%)
|
0%
|
79.2 |
41,960
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
615 |
26,693
(0%)
|
0%
|
79.2 |
48,690
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
289 |
33,008
(0%)
|
0%
|
79.2 |
22,880
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
268 |
17,125
(0%)
|
0%
|
79.2 |
21,218
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.17 per share. |
01 Jul 2019 |
92 |
12,474
(0%)
|
0%
|
79.2 |
7,284
|
Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel M. Bradbury
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
7,187
(0%)
|
0%
|
|
0
|
Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
7,284
(0%)
|
0%
|
|
0
|
Common Stock |
Gino Santini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
7,086
(0%)
|
0%
|
|
0
|
Common Stock |
Glenn P. Sblendorio
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel G. Welch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Daniel G. Welch
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
6,465
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
21,526
(0%)
|
0%
|
|
0
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
19,433
(0%)
|
0%
|
|
0
|
Common Stock |
Paolo Fundaro
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
9,126
(0%)
|
0%
|
|
0
|
Common Stock |
Luca Benatti
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
8,358
(0%)
|
0%
|
|
0
|
Common Stock |
Keith Gottesdiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
2,174 |
2,174
|
-
|
|
-
|
Option to Purchase Common Stock |
Nancy Miller-Rich
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
1,570 |
5,943
(0%)
|
0%
|
|
0
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.83 per share. |
27 May 2019 |
357 |
18,704
(0%)
|
0%
|
87.8 |
31,355
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.51 per share. |
23 May 2019 |
460 |
33,297
(0%)
|
0%
|
85.5 |
39,335
|
Common Stock |
Paolo Fundaro
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 May 2019 |
3,461 |
0
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
20 May 2019 |
3,288 |
0
|
-
|
|
-
|
Option to Purchase Common Stock |
Paolo Fundaro
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.50 per share. |
20 May 2019 |
3,288 |
17,863
(0%)
|
0%
|
21.5 |
70,692
|
Common Stock |
Paolo Fundaro
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.30 per share. |
20 May 2019 |
3,461 |
14,575
(0%)
|
0%
|
9.3 |
32,195
|
Common Stock |
Srinivas Akkaraju
|
Director |
Grant, award, or other acquisition of securities at price $ 83.50 per share. |
14 May 2019 |
119,760 |
330,697
(1%)
|
0%
|
83.5 |
9,999,960
|
Common Stock |
Luca Benatti
|
Director |
Purchase of securities on an exchange or from another person at price $ 83.50 per share. |
14 May 2019 |
1,200 |
7,556
(0%)
|
0%
|
83.5 |
100,200
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.73 per share. |
13 May 2019 |
711 |
27,118
(0%)
|
0%
|
83.7 |
59,532
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.66 per share. |
12 May 2019 |
319 |
19,280
(0%)
|
0%
|
86.7 |
27,645
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.57 per share. |
08 May 2019 |
128 |
12,566
(0%)
|
0%
|
87.6 |
11,209
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 86.28 per share. |
01 May 2019 |
2,000 |
39,499
(0%)
|
0%
|
86.3 |
172,560
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 May 2019 |
2,000 |
9,031
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
01 May 2019 |
2,000 |
41,499
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
Srinivas Akkaraju
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
25 Apr 2019 |
1,001 |
19,956
(0%)
|
0%
|
31.9 |
31,932
|
Common Stock |
Srinivas Akkaraju
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Apr 2019 |
1,001 |
979
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Apr 2019 |
2,499 |
0
|
-
|
|
-
|
Option to Purchase Common Stock |
Srinivas Akkaraju
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.50 per share. |
25 Apr 2019 |
2,499 |
18,955
(0%)
|
0%
|
21.5 |
53,729
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Apr 2019 |
1,750 |
21,175
|
-
|
|
-
|
Option to Purchase Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.63 per share. |
18 Apr 2019 |
1,750 |
19,599
(0%)
|
0%
|
54.6 |
95,603
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
15 Apr 2019 |
2,000 |
41,499
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Apr 2019 |
2,000 |
11,031
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 95.00 per share. |
15 Apr 2019 |
2,000 |
39,499
(0%)
|
0%
|
95 |
190,000
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 95.21 per share. |
13 Apr 2019 |
77 |
17,393
(0%)
|
0%
|
95.2 |
7,331
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
46 |
19,061
(0%)
|
0%
|
111.5 |
5,129
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
1,547 |
472,221
(1%)
|
0%
|
111.5 |
172,491
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
482 |
40,061
(0%)
|
0%
|
111.5 |
53,743
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 115.01 per share. |
01 Apr 2019 |
562 |
39,499
(0%)
|
0%
|
115.0 |
64,636
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
531 |
21,576
(0%)
|
0%
|
111.5 |
59,207
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 115.01 per share. |
01 Apr 2019 |
594 |
20,982
(0%)
|
0%
|
115.0 |
68,316
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
615 |
27,308
(0%)
|
0%
|
111.5 |
68,573
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
289 |
33,757
(0%)
|
0%
|
111.5 |
32,224
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
267 |
17,470
(0%)
|
0%
|
111.5 |
29,771
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.50 per share. |
01 Apr 2019 |
92 |
12,694
(0%)
|
0%
|
111.5 |
10,258
|
Common Stock |
Paolo Fundaro
|
Director |
Sale of securities on an exchange or to another person at price $ 107.45 per share. |
29 Mar 2019 |
2,171 |
11,114
(0%)
|
0%
|
107.4 |
233,272
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
01 Mar 2019 |
2,000 |
42,543
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2019 |
2,000 |
13,031
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 103.16 per share. |
01 Mar 2019 |
2,000 |
40,543
(0%)
|
0%
|
103.2 |
206,320
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 103.16 per share. |
27 Feb 2019 |
333 |
19,107
(0%)
|
0%
|
103.2 |
34,352
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.76 per share. |
27 Feb 2019 |
364 |
19,440
(0%)
|
0%
|
92.8 |
33,765
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.35 per share. |
23 Feb 2019 |
319 |
34,046
(0%)
|
0%
|
93.4 |
29,779
|
Common Stock |
Srinivas Akkaraju
|
Director |
Sale of securities on an exchange or to another person at price $ 128.78 per share. |
19 Feb 2019 |
23,438 |
210,937
(0%)
|
0%
|
128.8 |
3,018,346
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 111.51 per share. |
15 Feb 2019 |
2,000 |
40,543
(0%)
|
0%
|
111.5 |
223,020
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Feb 2019 |
2,000 |
15,031
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
15 Feb 2019 |
2,000 |
42,543
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.35 per share. |
13 Feb 2019 |
1,971 |
27,829
(0%)
|
0%
|
110.4 |
217,500
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.05 per share. |
12 Feb 2019 |
1,276 |
17,849
(0%)
|
0%
|
111.1 |
141,700
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.90 per share. |
08 Feb 2019 |
125 |
12,786
(0%)
|
0%
|
118.9 |
14,863
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
6,800 |
6,800
|
-
|
|
-
|
Option to Purchase Common Stock |
Christian Weyer
|
EVP, Research & Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
4,200 |
19,804
(0%)
|
0%
|
|
0
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
8,500 |
573,768
(1%)
|
0%
|
|
0
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
13,700 |
13,700
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
5,300 |
5,300
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
3,300 |
40,543
(0%)
|
0%
|
|
0
|
Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
10,700 |
10,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Ryan T. Sullivan
|
General Counsel and Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
6,600 |
29,800
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Bright
|
President, International |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
5,300 |
5,300
|
-
|
|
-
|
Option to Purchase Common Stock |
Lisa Bright
|
President, International |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
3,300 |
22,107
(0%)
|
0%
|
|
0
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
7,200 |
7,200
|
-
|
|
-
|
Option to Purchase Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
4,500 |
27,923
(0%)
|
0%
|
|
0
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
15,200 |
15,200
|
-
|
|
-
|
Option to Purchase Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
9,400 |
34,365
(0%)
|
0%
|
|
0
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
6,400 |
6,400
|
-
|
|
-
|
Option to Purchase Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
4,000 |
17,737
(0%)
|
0%
|
|
0
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
6,100 |
6,100
|
-
|
|
-
|
Option to Purchase Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
3,800 |
12,911
(0%)
|
0%
|
|
0
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
4,100 |
19,125
(0%)
|
0%
|
|
0
|
Common Stock |
Gail Cawkwell
|
SVP, Med Affairs, Safety & PV |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
16 Jan 2019 |
6,700 |
6,700
|
-
|
|
-
|
Option to Purchase Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.73 per share. |
13 Jan 2019 |
77 |
13,737
(0%)
|
0%
|
109.7 |
8,449
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 104.93 per share. |
07 Jan 2019 |
1,313 |
18,807
(0%)
|
0%
|
104.9 |
137,773
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 97.48 per share. |
04 Jan 2019 |
474 |
37,243
(0%)
|
0%
|
97.5 |
46,206
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
215 |
15,604
(0%)
|
0%
|
100.8 |
21,670
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
1,537 |
565,268
(1%)
|
0%
|
100.8 |
154,914
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
736 |
38,416
(0%)
|
0%
|
100.8 |
74,181
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jan 2019 |
2,000 |
17,031
|
-
|
|
-
|
Option to Purchase Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 97.45 per share. |
01 Jan 2019 |
699 |
37,717
(0%)
|
0%
|
97.5 |
68,118
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 98.28 per share. |
01 Jan 2019 |
2,000 |
38,416
(0%)
|
0%
|
98.3 |
196,560
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
01 Jan 2019 |
2,000 |
40,416
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
1,168 |
20,120
(0%)
|
0%
|
100.8 |
117,723
|
Common Stock |
Sandip S. Kapadia
|
CFO and Treasurer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
1,118 |
23,423
(0%)
|
0%
|
100.8 |
112,683
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
1,219 |
24,965
(0%)
|
0%
|
100.8 |
122,863
|
Common Stock |
Richard Kim
|
President US Comm & Strat Mktg |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
702 |
13,814
(0%)
|
0%
|
100.8 |
70,755
|
Common Stock |
David A. Ford
|
Chief Human Resources Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.79 per share. |
01 Jan 2019 |
423 |
9,111
(0%)
|
0%
|
100.8 |
42,634
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.90 per share. |
17 Dec 2018 |
2,000 |
41,152
(0%)
|
0%
|
31.9 |
63,800
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 106.62 per share. |
17 Dec 2018 |
2,000 |
39,152
(0%)
|
0%
|
106.6 |
213,240
|
Common Stock |
David Shapiro
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Dec 2018 |
2,000 |
19,031
|
-
|
|
-
|
Option to Purchase Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 112.12 per share. |
03 Dec 2018 |
700 |
21,788
(0%)
|
0%
|
112.1 |
78,486
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 113.22 per share. |
03 Dec 2018 |
200 |
21,588
(0%)
|
0%
|
113.2 |
22,645
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 111.00 per share. |
03 Dec 2018 |
300 |
21,288
(0%)
|
0%
|
111 |
33,300
|
Common Stock |
Lisa Bright
|
President, International |
Sale of securities on an exchange or to another person at price $ 111.23 per share. |
03 Dec 2018 |
3,800 |
22,488
(0%)
|
0%
|
111.2 |
422,691
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Sale of securities on an exchange or to another person at price $ 113.78 per share. |
27 Nov 2018 |
1,343 |
15,819
(0%)
|
0%
|
113.8 |
152,807
|
Common Stock |
Christian Weyer
|
EVP, Research & Development |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.66 per share. |
27 Nov 2018 |
1,438 |
17,162
(0%)
|
0%
|
108.7 |
156,253
|
Common Stock |
Lisa Bright
|
President, International |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.07 per share. |
24 Nov 2018 |
247 |
26,288
(0%)
|
0%
|
111.1 |
27,434
|
Common Stock |
Jerome B. Durso
|
Chief Operating Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.07 per share. |
23 Nov 2018 |
460 |
26,184
(0%)
|
0%
|
111.1 |
51,092
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Nov 2018 |
27,606 |
39
|
-
|
|
-
|
Option to Purchase Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 103.29 per share. |
15 Nov 2018 |
1,988 |
566,805
(1%)
|
0%
|
103.3 |
205,333
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 102.61 per share. |
15 Nov 2018 |
7,839 |
568,793
(1%)
|
0%
|
102.6 |
804,374
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 101.48 per share. |
15 Nov 2018 |
7,949 |
576,632
(1%)
|
0%
|
101.5 |
806,687
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 100.38 per share. |
15 Nov 2018 |
9,830 |
584,581
(1%)
|
0%
|
100.4 |
986,735
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.67 per share. |
15 Nov 2018 |
27,606 |
594,411
(2%)
|
0%
|
8.7 |
239,253
|
Common Stock |
Mark Pruzanski
|
Director, President & CEO |
Sale of securities on an exchange or to another person at price $ 101.13 per share. |
15 Nov 2018 |
3,521 |
566,805
(1%)
|
0%
|
101.1 |
356,088
|
Common Stock |